Filing Flows › HCW Biologics (HCWB) › Recalls, complaints & regulation
HCW Biologics (HCWB): clinical trials
HCW Biologics (HCWB) beyond its filings: 1 active clinical trial.
HCW Biologics' latest quarter
HCW Biologics, Q2 2026: revenue $136K (21× year over year), net loss $5.2M, operating cash flow −$4.0M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does HCW Biologics have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.